Edition:
United States

Assembly Biosciences Inc (ASMB.OQ)

ASMB.OQ on NASDAQ Stock Exchange Capital Market

46.17USD
4:00pm EDT
Change (% chg)

$-1.87 (-3.89%)
Prev Close
$48.04
Open
$47.52
Day's High
$48.38
Day's Low
$45.85
Volume
54,596
Avg. Vol
68,456
52-wk High
$66.89
52-wk Low
$18.60

Chart for

About

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $965.06
Shares Outstanding(Mil.): 20.55
Dividend: --
Yield (%): --

Financials

  ASMB.OQ Industry Sector
P/E (TTM): -- 29.92 34.14
EPS (TTM): -2.90 -- --
ROI: -40.22 13.64 13.17
ROE: -63.11 15.43 15.14

BRIEF-Assembly Biosciences Q1 Loss Per Share $0.80

* ASSEMBLY BIOSCIENCES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 07 2018

BRIEF-Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients

* ASSEMBLY BIOSCIENCES PRESENTS POSITIVE INTERIM DATA FROM PHASE 1A AND 1B STUDIES OF ABI-H0731 IN HBV PATIENTS IN A LATE-BREAKER SESSION AT THE EASL CONFERENCE

Apr 12 2018

BRIEF-Assembly Biosciences Says Graham Cooper Joined Assembly As New CFO And COO Effective March 8​

* ASSEMBLY BIOSCIENCES ANNOUNCES ADDITIONS TO MANAGEMENT TEAM AND BOARD OF DIRECTORS

Mar 12 2018

BRIEF-Assembly Biosciences Files For Mixed Shelf Of Up To $250 Mln

* ASSEMBLY BIOSCIENCES FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING Source text: (http://bit.ly/2CnCeGR) Further company coverage:

Dec 29 2017

Competitors

  Price Chg
Kyowa Hakko Kirin Co Ltd (4151.T) ¥2,273 --

Earnings vs. Estimates